EP3370744A4 - Le blocage du cycle cellulaire améliore l'efficacité de production de cellules souches pluripotentes induites - Google Patents

Le blocage du cycle cellulaire améliore l'efficacité de production de cellules souches pluripotentes induites Download PDF

Info

Publication number
EP3370744A4
EP3370744A4 EP16862739.6A EP16862739A EP3370744A4 EP 3370744 A4 EP3370744 A4 EP 3370744A4 EP 16862739 A EP16862739 A EP 16862739A EP 3370744 A4 EP3370744 A4 EP 3370744A4
Authority
EP
European Patent Office
Prior art keywords
stem cells
cell cycle
pluripotent stem
induced pluripotent
improves efficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16862739.6A
Other languages
German (de)
English (en)
Other versions
EP3370744A1 (fr
Inventor
Robin Y. SMITH
Marcie A. Glicksman
Nikhat F. ZAIDI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seaport Diagnostics Inc
Original Assignee
Orig3n Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orig3n Inc filed Critical Orig3n Inc
Publication of EP3370744A1 publication Critical patent/EP3370744A1/fr
Publication of EP3370744A4 publication Critical patent/EP3370744A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
EP16862739.6A 2015-11-02 2016-10-27 Le blocage du cycle cellulaire améliore l'efficacité de production de cellules souches pluripotentes induites Withdrawn EP3370744A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562249520P 2015-11-02 2015-11-02
PCT/US2016/059112 WO2017079029A1 (fr) 2015-11-02 2016-10-27 Le blocage du cycle cellulaire améliore l'efficacité de production de cellules souches pluripotentes induites

Publications (2)

Publication Number Publication Date
EP3370744A1 EP3370744A1 (fr) 2018-09-12
EP3370744A4 true EP3370744A4 (fr) 2019-04-17

Family

ID=58662634

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16862739.6A Withdrawn EP3370744A4 (fr) 2015-11-02 2016-10-27 Le blocage du cycle cellulaire améliore l'efficacité de production de cellules souches pluripotentes induites

Country Status (6)

Country Link
EP (1) EP3370744A4 (fr)
JP (1) JP2018531610A (fr)
KR (1) KR20180072817A (fr)
CN (1) CN108348556A (fr)
IL (1) IL258640A (fr)
WO (1) WO2017079029A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107589002B (zh) * 2017-09-08 2020-05-29 杭州市妇产科医院 一种诱导多能干细胞染色体的制备方法
WO2019131940A1 (fr) * 2017-12-28 2019-07-04 株式会社カネカ Inhibiteur de l'agrégation de cellules souches pluripotentes
CN110016460A (zh) * 2018-01-09 2019-07-16 中国农业大学 一种高效鸡胚胎原代成纤维细胞g2/m期同步化方法
CN108531447B (zh) * 2018-04-13 2021-11-23 上海市生物医药技术研究院 调节精子运动能力及辅助生殖的化合物及其用途
CN115531382B (zh) * 2021-06-29 2024-01-30 中国科学院生物物理研究所 喹啉噻唑啉酮衍生物Ro-3306在治疗β-冠状病毒感染中的应用
CN113462638B (zh) * 2021-06-30 2022-10-25 呈诺再生医学科技(珠海横琴新区)有限公司 一种高效无遗传修饰的iPSC诱导、产业化单克隆挑取平台及应用
WO2023243679A1 (fr) * 2022-06-17 2023-12-21 学校法人日本医科大学 Procédé de production d'un vecteur viral de titre élevé

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010111422A2 (fr) * 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Génération de cellules souches pluripotentes induites en utilisant deux facteurs et l'inactivation de p53
WO2011060100A1 (fr) * 2009-11-11 2011-05-19 Sanford-Burnham Medical Research Institute Procédé de production et de régulation de cellules ips et compositions associées
WO2012136841A1 (fr) * 2011-04-08 2012-10-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédé pour régénérer des cellules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
CA2278645A1 (fr) * 1997-01-23 1998-07-30 The Johns Hopkins University School Of Medicine Caracterisation du transcriptome de levure
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
JP5688970B2 (ja) * 2008-07-07 2015-03-25 タカラバイオ株式会社 多能性幹細胞の製造方法
CN104278008B (zh) * 2013-07-12 2020-08-21 北京宏冠再生医学科技有限公司 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途
JP6232907B2 (ja) * 2013-10-09 2017-11-22 富士レビオ株式会社 融合細胞およびその作製方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010111422A2 (fr) * 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Génération de cellules souches pluripotentes induites en utilisant deux facteurs et l'inactivation de p53
WO2011060100A1 (fr) * 2009-11-11 2011-05-19 Sanford-Burnham Medical Research Institute Procédé de production et de régulation de cellules ips et compositions associées
WO2012136841A1 (fr) * 2011-04-08 2012-10-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédé pour régénérer des cellules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KESHI CHEN ET AL: "Gadd45a is a heterochromatin relaxer that enhances iPS cell generation", EMBO REPORTS, vol. 17, no. 11, 4 October 2015 (2015-10-04), pages 1641 - 1656, XP055564950, ISSN: 1469-3178, DOI: 10.15252/embr.201642402 *
See also references of WO2017079029A1 *

Also Published As

Publication number Publication date
CN108348556A (zh) 2018-07-31
JP2018531610A (ja) 2018-11-01
IL258640A (en) 2018-06-28
WO2017079029A1 (fr) 2017-05-11
KR20180072817A (ko) 2018-06-29
EP3370744A1 (fr) 2018-09-12

Similar Documents

Publication Publication Date Title
IL258640A (en) A cell cycle inhibitor improves efficiency in the generation of induced pluripotent stem cells
HK1246342A1 (zh) 產生源自幹細胞的β細胞的方法及其用途
SG10201810110RA (en) Extreme pcr
HK1244017A1 (zh) 在間充質幹細胞中批量生產蛋白質的方法
EP2811011A4 (fr) Nécessaire de culture cellulaire et son procédé d'utilisation
HK1220992A1 (zh) 用於產生心外膜細胞的方法和組合物
HK1219050A1 (zh) 免疫保護性原代間充質幹細胞和方法
EP3060650A4 (fr) Mise en culture de cellules souches pluripotentes
IL263779A (en) Protein production in plant cells
IL266554A (en) Stem cells derived from Schwann cells
PL3125302T3 (pl) Ogniwo słoneczne
SG11201706090SA (en) Cell culturing method and kit
PL3303778T3 (pl) Ulepszenia w magazynowaniu energi
SG11201706886PA (en) Cell culture method for mesenchymal stem cells
EP3383182C0 (fr) Procédés de production de cellules souches hématopoïétiques fonctionnelles
SG11202004935UA (en) Cell culture methods
PL3365432T3 (pl) Terapia komórkami macierzystymi oparta na komórkach macierzystych pozyskiwanych z tkanki tłuszczowej
GB201710533D0 (en) Improvements in or relating to energy generation
HRP20171417B8 (hr) Fotonaponska solarna ćelija
EP3095864A4 (fr) Nouveau procédé d'étiquetage d'une cellule responsable de la cancérisation dans des cellules souches, et méthode thérapeutique
IL270880A (en) Cell culture methods
GB201504291D0 (en) PV cells
EP3119877A4 (fr) Procédés se rapportant à des cellules pluripotentes
GB201504760D0 (en) PV cells
ZA201705848B (en) Improvement of efficiency in power plants

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190319

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/071 20100101ALI20190313BHEP

Ipc: A61K 35/17 20150101ALI20190313BHEP

Ipc: A61K 35/545 20150101AFI20190313BHEP

Ipc: A61K 35/12 20150101ALI20190313BHEP

Ipc: A61K 35/35 20150101ALI20190313BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210621

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220104